A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2011
11/10/2011	US20110275681 Novel solid forms of epalrestat
11/10/2011	US20110275680 Noxel oxime derivatives of 3, 5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
11/10/2011	US20110275679 Flupirtine hydrochloride maleic acid cocrystal
11/10/2011	US20110275678 New Pyridine Derivatives as Leptin Receptor Modulator Mimetics
11/10/2011	US20110275677 Indole compounds bearing aryl or heteroaryl groups having sphingosine-1-phosphate (s1p) receptor biological activity
11/10/2011	US20110275674 Small Molecules Modulator of Epigenetic Regulation and Their Therapeutic Applications
11/10/2011	US20110275673 Inhibitors of sphingosine kinase 1
11/10/2011	US20110275672 Methods for treating cancers using polymorphic forms of 3-(4-amino-1-oxo-1,3 dihydro-isoindol-2-yl)-piperidine-2,6-dione
11/10/2011	US20110275671 Dihydroindolinone derivatives
11/10/2011	US20110275670 New Compounds VII
11/10/2011	US20110275669 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine
11/10/2011	US20110275668 Compound with antimalarial activity and antimalarial drug containing the same as active ingredient
11/10/2011	US20110275667 Compositions useful for treating gastroesophageal reflux disease
11/10/2011	US20110275666 Activated blood coagulation factor x (fxa) inhibitor
11/10/2011	US20110275665 Glucokinase activators
11/10/2011	US20110275664 Method for treating drug and behavioral addictions
11/10/2011	US20110275663 N-Acylthiourea and N-Acylurea Inhibitors of the Hedgehog Protein Signalling Pathway
11/10/2011	US20110275662 Methods of improving skin quality
11/10/2011	US20110275661 Tricyclic nitrogen compounds used as antibacterials
11/10/2011	US20110275660 Beta carboline sulphonylurea derivatives as ep4 receptor antagonists
11/10/2011	US20110275659 Tacrolimus For Improved Treatment Of Transplant Patients
11/10/2011	US20110275658 Opioid-containing oral pharmaceutical compositions and methods
11/10/2011	US20110275657 Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics
11/10/2011	US20110275656 3H-Imidazo [4, 5-C] Pyridine- 6 -Carboxamides As Anti-Inflammatory Agents
11/10/2011	US20110275655 Pyrimidinecarboxamide derivatives as inhibitors of syk kinase
11/10/2011	US20110275654 Long term treatment of hiv-infection with tmc278
11/10/2011	US20110275653 Heterocyclic compounds and their uses
11/10/2011	US20110275652 2,2-bis-(hydroxymethyl)cyclopropylidenemethyl-purines and -pyrimidines as antiviral agents
11/10/2011	US20110275651 Fused ring heteroaryl kinase inhibitors
11/10/2011	US20110275650 Methods and compositions related to targeting monoacylglycerol lipase
11/10/2011	US20110275649 Combination therapy for the prevention of statin induced diabetes
11/10/2011	US20110275648 Flurbiprofen analogs and methods of use in treating cancer
11/10/2011	US20110275647 Pyrimidin-4-(3h)-one derivatives
11/10/2011	US20110275646 Novel Compounds for Treatment of Cancer and Disorders Associated with Angiogenesis Function
11/10/2011	US20110275645 Small Molecules for Inhibition of Protein Kinases
11/10/2011	US20110275644 Biological markers predictive of anti-cancer response to insulin-like growth factor-1 receptor kinase inhibitors
11/10/2011	US20110275643 Aroylquinoline compounds
11/10/2011	US20110275642 New method for obtaining 5-amino 2,3-dihydrophthalazine-1,4-dione alkali metal salts and their use in medicine
11/10/2011	US20110275641 Preventives or remedies for Alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275640 Preventives or remedies for alzheimer's disease, or amyloid protein fibril-formation inhibitors, which include a nitrogen-containing heteroaryl compound
11/10/2011	US20110275639 C5aR ANTAGONISTS
11/10/2011	US20110275638 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275637 Piperazine derivatives and their use as leptin receptor modulators
11/10/2011	US20110275636 Desazadesferrothiocin and desazadesferrothiocin polyether analogues as metal chelation agents
11/10/2011	US20110275635 Small molecule inhibitors of nads, namnat, and nmnat
11/10/2011	US20110275634 Dual-acting pyrazole antihypertensive agents
11/10/2011	US20110275633 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
11/10/2011	US20110275632 Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/2011	US20110275631 Heteroaryl Substituted Indole Compounds Useful as MMP-13 Inhibitors
11/10/2011	US20110275630 Isoindolinone kinase inhibitors
11/10/2011	US20110275629 Pyridazino-pyridinone Compounds and Methods of Use
11/10/2011	US20110275628 Novel pyrazole-3-carboxamide derivative having 5-ht2b receptor antagonist activity
11/10/2011	US20110275627 Indolizine inhibitors of leukotriene production
11/10/2011	US20110275626 Formulation for oral transmucosal administration of analgesic and/or antispasmodic molecules
11/10/2011	US20110275625 Heteroaryl Diamide Compounds Useful as MMP-13 Inhibitors
11/10/2011	US20110275624 Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors
11/10/2011	US20110275623 Bi-functional pyrazolopyridine compounds
11/10/2011	US20110275622 Bi-functional quinoline analogs
11/10/2011	US20110275621 Hiv integrase inhibitors
11/10/2011	US20110275620 Method for preventing or treating a disease related to the glucocorticoid receptor
11/10/2011	US20110275619 Inhibitors of bace1 and methods for treating alzheimer's disease
11/10/2011	US20110275618 Novel low concentration meloxicam tablets
11/10/2011	US20110275617 Ophthalmic composition
11/10/2011	US20110275616 Combination Analgesic Employing Opioid and Neutral Antagonist
11/10/2011	US20110275615 Novel substituted amides, their preparation and use
11/10/2011	US20110275614 Methods for the preparation of ivabradine sulfate and form i crystal thereof
11/10/2011	US20110275613 Organic compounds
11/10/2011	US20110275612 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/10/2011	US20110275611 Chemical compounds
11/10/2011	US20110275610 Substituted pyrazole compounds
11/10/2011	US20110275609 Bicyclic pyrazolo-heterocycles
11/10/2011	US20110275608 Piperidine-containing compounds and use thereof
11/10/2011	US20110275607 Nuclear transport modulators and uses thereof
11/10/2011	US20110275606 Substituted porphyrins
11/10/2011	US20110275605 Postprandial Hyperglycemia-Improving Agent
11/10/2011	US20110275604 Aminoalkylsterol compounds with antitumoral and neuroprotective activity
11/10/2011	US20110275603 Novel immunomodulator and anti-inflammatory compounds
11/10/2011	US20110275602 Pharmaceutical association, compositions for topical use, forms of dosage and method of treatment of acute or chronic otitis in pet animals
11/10/2011	US20110275601 Very low-dosed solid oral dosage forms for hrt
11/10/2011	US20110275600 Methods for increasing endogenous plasmalogen levels
11/10/2011	US20110275597 Pharmaceutical composition
11/10/2011	US20110275596 Methods for treating neoplasia and for identifying compositions useful in such therapy
11/10/2011	US20110275595 Urea derivatives of substituted nortropanes, medicaments containing such compounds and their use
11/10/2011	US20110275594 Oral dosage form
11/10/2011	US20110275593 Stabilized ophthalmic galactomannan formulations
11/10/2011	US20110275591 Cocktail for modulation of alzheimer's disease
11/10/2011	US20110275590 Conjugates for cancer therapy and diagnosis
11/10/2011	US20110275589 3,5-DISUBSTITUTED AND 3,5,7-TRISUBSTITUTED-3H-OXAZOLO AND 3H-THIAZOLO[4,5-d]PYRIMIDIN-2-ONE COMPOUNDS AND PRODRUGS THEREOF
11/10/2011	US20110275588 Fused Diimidazodiazepine Compounds and Methods of Use and Manufacture Thereof
11/10/2011	US20110275587 Topical delivery of viscous medications for the treatment of diseases associated with chronic sinusitis
11/10/2011	US20110275586 Antibacterial aminoglycoside analogs
11/10/2011	US20110275585 Targeted delivery of drugs, therapeutic nucleic acids and functional nucleic acids to mammalian cells via intact killed bacterial cells
11/10/2011	US20110275584 Prevention and treatment of inflammation-induced and/or immune-mediated bone loss
11/10/2011	US20110275582 Topical avermectin formulations and methods for elimination and prophylaxis of susceptible and treatment resistant strains of head lice
11/10/2011	US20110275581 Nuclear export inhibitors of topoisomerase ii alpha
11/10/2011	US20110275580 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
11/10/2011	US20110275579 Anti-diabetic extract of rooibos
11/10/2011	US20110275578 Treatment of nephrolithiasis and urolithiasis using 1,2,3,4,6-penta-o-galloyl-beta-d-glucose (pgg)
11/10/2011	US20110275577 Methods of treating dermatologic, gynecologic, and genital disorders with caffeic acid analogs
11/10/2011	US20110275576 Carbohydrate-Cyclopamine Conjugates as Anticancer Agents

1 ... 1487 1488 1489 1490 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 ... 7860